| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს ანშენ ფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾1.8m₾2.2m |
| Revenue growth | -100.0% | -15.9% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | ₾611k₾355k |
| EBITDA margin | -29687.2%-11.6% | 33.4%16.3% |
| Net profit | -₾258k-₾726k | ₾520k₾288k |
| Net margin | -29249.2%-17.7% | 28.4%13.2% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾2.7m₾2.3m |
| Total equity | -₾780k-₾522k | ₾2.7m₾2.2m |
| ROE | — | 19.2%13.1% |